Orally Disintegrating Tramadol

Available only with a prescription, orally disintegrating tramadol is a drug used to treat pain in adults. It comes in the form of a rapidly dissolving tablet and is usually taken two to four times a day. Some of the most commonly reported side effects include constipation, dizziness, and nausea. It should be noted that this drug has a high potential for abuse.

What Is Orally Disintegrating Tramadol?

This medication is no longer available, as it has been discontinued by the manufacturer. Other tramadol products are still available. 
 
Orally disintegrating tramadol (Rybix™ ODT) is a prescription pain medication approved for treating moderate-to-moderately severe pain in adults. It comes in the form of a tablet that dissolves rapidly on the tongue, without any need for water.
 
(Click What Is Orally Disintegrating Tramadol Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

Just like any medicine, orally disintegrating tramadol can cause side effects. However, not everyone who takes the drug will experience problems. Some people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious reactions are less common.
 
Common side effects seen with orally disintegrating tramadol include but are not limited to:
 
(Click Side Effects of Orally Disintegrating Tramadol to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
Alternative Therapies for Pain Management

Orally Disintegrating Tramadol Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.